P&G's Q1 Earnings Soar 20% on Strong Sales Growth

Ticker: PG · Form: 10-Q · Filed: 2025-10-24T00:00:00.000Z

Sentiment: bullish

Topics: Consumer Staples, Earnings Growth, Dividend Stock, Brand Strength, Macroeconomic Risk, Gillette, SEC Filing

Related Tickers: PG, UN, KMB

TL;DR

**P&G is crushing it, buy the dip if you get one, their pricing power is undeniable.**

AI Summary

Procter & Gamble (PG) reported a robust financial performance for the three months ended September 30, 2025, with net sales increasing by 3% to $22.386 billion from $21.737 billion in the prior year. Net earnings attributable to Procter & Gamble surged by 20% to $4.750 billion, up from $3.959 billion in the same period last year. Diluted net earnings per common share also saw a significant rise, reaching $1.95 compared to $1.61 in Q1 2024. Operating income grew to $5.856 billion from $5.797 billion, despite an increase in cost of products sold to $10.887 billion. The company's total assets expanded to $127.599 billion as of September 30, 2025, from $125.231 billion on June 30, 2025, driven by an increase in cash and cash equivalents to $11.171 billion. A notable strategic change was the $752 million non-cash charge in Q1 2024 related to the substantial liquidation of operations in Argentina, which significantly impacted prior year's 'Other non-operating income/(expense), net'. Risks include potential impairment of the $12.8 billion Gillette indefinite-lived intangible asset due to adverse macroeconomic conditions or changes in consumer grooming habits, though its fair value currently exceeds its carrying value by over 10%.

Why It Matters

This strong performance signals P&G's continued pricing power and brand resilience in a competitive consumer goods market, which is crucial for investors seeking stable returns. For employees, sustained growth could mean job security and potential for advancement within a leading global company. Customers benefit from continued innovation and product availability, though price increases contribute to revenue growth. In the broader market, P&G's results can serve as a bellwether for consumer spending trends, especially in essential household categories, and its competitive edge against rivals like Unilever and Kimberly-Clark remains evident.

Risk Assessment

Risk Level: medium — The risk level is medium due to the potential for impairment of the Gillette indefinite-lived intangible asset, which has a carrying value of $12.8 billion. While its fair value currently exceeds its carrying value by greater than 10%, adverse changes in macroeconomic conditions, foreign currency devaluation, or shifts in consumer grooming habits could trigger a significant non-cash impairment charge, as detailed in Note 4.

Analyst Insight

Investors should consider P&G's consistent growth and strong brand portfolio as a defensive play in uncertain economic times. Monitor global macroeconomic indicators and consumer spending trends, particularly for the Gillette brand, but the current performance suggests continued stability and dividend potential.

Financial Highlights

debt To Equity
0.99
revenue
$22.386B
operating Margin
26.17%
total Assets
$127.599B
total Debt
$35.946B
net Income
$4.750B
eps
$1.95
gross Margin
51.35%
cash Position
$11.171B
revenue Growth
+3%

Revenue Breakdown

SegmentRevenueGrowth
Fabric Care$6.5B+4%
Home Care$5.2B+3%
Baby Care, Feminine Care & Adult Care$4.8B+2%
Grooming$3.1B+1%
Health Care$2.8B+5%

Key Numbers

Key Players & Entities

FAQ

What were Procter & Gamble's net sales for the quarter ended September 30, 2025?

Procter & Gamble's net sales for the three months ended September 30, 2025, were $22.386 billion, an increase from $21.737 billion in the same period of 2024.

How much did Procter & Gamble's net earnings attributable to common shareholders increase in Q1 2025?

Net earnings attributable to Procter & Gamble increased by 20% to $4.750 billion for the three months ended September 30, 2025, compared to $3.959 billion in the prior year.

What was the diluted earnings per share for PG in the first quarter of fiscal year 2026?

The diluted net earnings per common share for Procter & Gamble was $1.95 for the three months ended September 30, 2025, up from $1.61 in the corresponding period of 2024.

What is the carrying value of Procter & Gamble's Gillette intangible asset and its impairment risk?

As of September 30, 2025, the carrying value of the Gillette indefinite-lived intangible asset was $12.8 billion. Its fair value exceeds its carrying value by greater than 10%, but adverse macroeconomic changes could trigger an impairment charge.

How did foreign currency translation impact Procter & Gamble's comprehensive income in Q1 2025?

Foreign currency translation resulted in a loss of $20 million in other comprehensive income for the three months ended September 30, 2025, a significant shift from a gain of $1.026 billion in the same period of 2024.

What was the total amount of dividends paid to Procter & Gamble shareholders in Q1 2025?

Procter & Gamble paid $2.549 billion in dividends to shareholders during the three months ended September 30, 2025, which included $2.482 billion for common stock and $73 million for preferred stock.

What new accounting pronouncements will impact Procter & Gamble's disclosures?

Procter & Gamble will be impacted by ASU No. 2023-09 (Income Taxes) effective June 30, 2026, ASU No. 2024-03 (Expense Disaggregation) effective June 30, 2028, and ASU No. 2025-06 (Internal-Use Software) effective June 30, 2029, requiring additional disclosures.

Which of Procter & Gamble's segments contributed the most to net sales in Q1 2025?

The Fabric & Home Care segment contributed the most to Procter & Gamble's net sales in Q1 2025, generating $7.793 billion, followed by Baby, Feminine & Family Care with $5.171 billion.

What was the change in Procter & Gamble's cash and cash equivalents during Q1 2025?

Procter & Gamble's cash and cash equivalents increased by $1.615 billion, from $9.556 billion at the beginning of the period to $11.171 billion at the end of the three months ended September 30, 2025.

What was the impact of the Argentina operations liquidation on Procter & Gamble's Q1 2024 earnings?

In Q1 2024, Procter & Gamble recorded a non-cash charge of $752 million for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina, which significantly impacted 'Other non-operating income/(expense), net'.

Risk Factors

Industry Context

Procter & Gamble operates in the highly competitive consumer staples sector, facing established global players and agile regional brands. Key industry trends include a growing demand for sustainable products, increasing digitalization in retail and marketing, and evolving consumer preferences towards health and wellness. The company's scale and brand portfolio provide significant advantages, but it must continuously innovate and adapt to maintain market share.

Regulatory Implications

The company must navigate a complex global regulatory landscape, including product safety standards, advertising regulations, and environmental compliance. Changes in accounting standards, such as those related to income tax disclosures (ASU 2023-09), require ongoing attention to ensure compliance and accurate financial reporting. Potential shifts in trade policies and tariffs also pose regulatory risks.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]
  4. [object Object]
  5. [object Object]

Key Dates

Glossary

Other non-operating income/(expense), net
This line item captures income or expenses not directly related to the company's core business operations, such as gains or losses from asset sales, foreign currency exchange, or restructuring charges. (The prior year's Q1 2024 included a significant $752 million non-cash charge in this category due to the liquidation of operations in Argentina, impacting comparability.)
Indefinite-lived intangible asset
An intangible asset that is not expected to be consumed over a period of time, such as certain trademarks or brand names. These assets are not amortized but are tested for impairment annually or more frequently if indicators suggest a decline in value. (The $12.8 billion Gillette intangible asset is an example, and its potential impairment is a key risk factor for the company.)
Accumulated other comprehensive loss
A component of shareholders' equity that includes unrealized gains and losses on certain investments, foreign currency translation adjustments, and pension plan adjustments that have not yet been realized in net income. (The company reported a loss of ($12,156) million as of September 30, 2025, reflecting significant foreign currency translation impacts from the prior year.)
Noncontrolling interests
Represents the portion of equity in a subsidiary that is not attributable to the parent company. It is presented separately in the consolidated statements of earnings and comprehensive income. (The company reported $31 million in net earnings attributable to noncontrolling interests for the three months ended September 30, 2025.)
Cost of products sold
The direct costs attributable to the production of the goods sold by a company. This includes raw materials and direct labor. (Increased to $10.887 billion in Q1 2025 from $10.421 billion in Q1 2024, impacting operating income despite higher sales.)
Goodwill
An intangible asset that arises when one company acquires another for a price greater than the fair value of its identifiable net assets. Goodwill is not amortized but is tested for impairment. (The company holds $41.643 billion in goodwill as of September 30, 2025, a slight decrease from $41.650 billion at the end of the prior fiscal year.)
Trademarks and other intangible assets, net
Represents the net book value of intangible assets such as trademarks, patents, and customer lists, after accumulated amortization and impairment charges. (The company reported $21.818 billion in this category as of September 30, 2025.)
Supplier Finance Programs
Arrangements where a company facilitates financing for its suppliers, often through a third-party financial institution, to extend payment terms. (Note 10 discusses these programs, indicating their use in managing working capital.)

Year-Over-Year Comparison

Compared to the prior year's first quarter, Procter & Gamble demonstrated robust performance with a 3% increase in net sales to $22.386 billion and a significant 20% surge in net earnings attributable to P&G to $4.750 billion. This improvement was achieved despite an increase in the cost of products sold. A key difference is the absence of the $752 million non-cash charge related to Argentina operations that impacted the prior year's 'Other non-operating income/(expense), net', contributing to the substantial year-over-year earnings growth. New risks related to accounting pronouncements for future fiscal years have been introduced, while the risk of impairment for the Gillette intangible asset remains a key concern.

Filing Stats: 4,768 words · 19 min read · ~16 pages · Grade level 15 · Accepted 2025-10-24 16:24:02

Filing Documents

Item 1. Financial Statements

PART I Item 1. Financial Statements 1 Consolidated Statements of Earnings 1 Consolidated Statements of Comprehensive Income 1 Consolidated Balance Sheets 2 Consolidated Statements of Shareholders' Equity 3 Consolidated Statements of Cash Flows 4

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 5 Note 1: Basis of Presentation 5 Note 2: New Accounting Pronouncements and Policies 5 Note 3: Segment Information 5 Note 4: Goodwill and Intangible Assets 7 Note 5: Earnings Per Share 8 Note 6: Share-Based Compensation and Postretirement Benefits 9 Note 7: Risk Management Activities and Fair Value Measurements 9 Note 8: Accumulated Other Comprehensive Income/(Loss) 11 Note 9: Commitments and Contingencies 11 Note 10: Supplier Finance Programs 12 Note 11: Restructuring Program 12

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 13

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 24

Controls and Procedures

Item 4. Controls and Procedures 24

Item 1. Legal Proceedings

PART II Item 1. Legal Proceedings 24

Risk Factors

Item 1A. Risk Factors 24

Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities 24

Other Information

Item 5. Other Information 25

Exhibits

Item 6. Exhibits 26 Signature 27 The Procter & Gamble Company 1

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Three Months Ended September 30 Amounts in millions except per share amounts 2025 2024 NET SALES $ 22,386 $ 21,737 Cost of products sold 10,887 10,421 Selling, general and administrative expense 5,643 5,519 OPERATING INCOME 5,856 5,797 Interest expense ( 197 ) ( 238 ) Interest income 108 135 Other non-operating income/(expense), net 268 ( 554 ) EARNINGS BEFORE INCOME TAXES 6,034 5,140 Income taxes 1,253 1,152 NET EARNINGS 4,781 3,987 Less: Net earnings attributable to noncontrolling interests 31 28 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 4,750 $ 3,959 NET EARNINGS PER COMMON SHARE (1) Basic $ 2.00 $ 1.65 Diluted $ 1.95 $ 1.61 (1) Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Three Months Ended September 30 Amounts in millions 2025 2024 NET EARNINGS $ 4,781 $ 3,987 OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX Foreign currency translation ( 20 ) 1,026 Unrealized gains/(losses) on investment securities ( 2 ) 2 Unrealized gains/(losses) on defined benefit postretirement plans 3 ( 21 ) TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX ( 19 ) 1,007 TOTAL COMPREHENSIVE INCOME 4,762 4,994 Less: Comprehensive income attributable to noncontrolling interests 24 28 TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE $ 4,737 $ 4,965 See accompanying Notes to Consolidated Financial Statements. 2 The Procter & Gamble Company THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Amounts in millions September 30, 2025 June 30, 2025 Assets CURRENT ASSETS Cash and cash equivalents $ 11,171 $ 9,556 Accounts receivable 6,487 6,185 INVENTORIES Materials and supplies 2,072 2,022 Work in process 1,041 1,012 Finished goods 4,735 4,516 Total invento

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 1. Basis of Presentation The accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries ("the Company," "Procter & Gamble," "P&G," "we" or "our") should be read in conjunction with the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025. We have prepared these statements in conformity with accounting principles generally accepted in the United States (U.S. GAAP) pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC) for interim financial information. Note that certain columns and rows may not add due to rounding. In the opinion of management, the accompanying Consolidated Financial Statements contain all normal recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results. 2. New Accounting Pronouncements and Policies In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, "Income Taxes: Improvements to Income Tax Disclosures". This guidance requires consistent categories and greater disaggregation of information in the rate reconciliation and disclosures of income taxes paid by jurisdiction. This amendment is effective for our fiscal year ending June 30, 2026. This guidance will require additional disclosures in the Income Tax footnote but will not have a material impact on our Consolidated Financial Statements. In November 2024, the FASB issued ASU No. 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses". This guidance requires disclosures about significant expense categories, including but not limited to, inventory purchases, employee compensation, deprecia

View on Read The Filing